Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05973630
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-07
First Post:
2023-07-24
Brief Title:
ATA-200 Dose-escalation Gene Therapy Trial in Patients with LGMDR5
Sponsor:
Atamyo Therapeutics
Organization:
Atamyo Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-24
First Submit QC Date:
August 1 2023
Study First Post Date:
2023-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-09
Last Update Post Date:
2024-03-07
Last Update Post Date Type:
ACTUAL